b*********n
发帖数: 13256 | 1 growth降得很厉害，会不会砸到300？
Revenue missed and bad forecast:
Biogen also updated its full-year financial guidance. Revenue growth is now
expected to be in the range of 6% to 8% above 2014 revenues of $9.7 billion.
The company’s previous guidance called for revenue growth of 14% to 16%
above last year’s revenues. Adjusted EPS guidance also was lowered from a
prior range of $16.60 to $17.00 to a new range of $15.50 to $15.95. |
t****y
发帖数: 3494 | 2 abbv也miss了，今天药股要大调整
now
billion.
【在 b*********n 的大作中提到】
: growth降得很厉害，会不会砸到300？
: Revenue missed and bad forecast:
: Biogen also updated its full-year financial guidance. Revenue growth is now
: expected to be in the range of 6% to 8% above 2014 revenues of $9.7 billion.
: The company’s previous guidance called for revenue growth of 14% to 16%
: above last year’s revenues. Adjusted EPS guidance also was lowered from a
: prior range of $16.60 to $17.00 to a new range of $15.50 to $15.95.
|
s*****3
发帖数: 1673 | |
f********d
发帖数: 796 | |
t****y
发帖数: 3494 | 5 大水枪lihai，快到300了
now
billion.
【在 b*********n 的大作中提到】
: growth降得很厉害，会不会砸到300？
: Revenue missed and bad forecast:
: Biogen also updated its full-year financial guidance. Revenue growth is now
: expected to be in the range of 6% to 8% above 2014 revenues of $9.7 billion.
: The company’s previous guidance called for revenue growth of 14% to 16%
: above last year’s revenues. Adjusted EPS guidance also was lowered from a
: prior range of $16.60 to $17.00 to a new range of $15.50 to $15.95.
|
u******n
发帖数: 5727 | |
b********t
发帖数: 373 | |
b*********n
发帖数: 13256 | |
